ArticleInternational journal of obesity (2005)2026
Plasma metabolites may inhibit childhood obesity by regulating ferroptosis through SMPD1 and SIRT3.
Article in International journal of obesity (2005), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate the causal relationship between plasma metabolites and ferroptosis-related genes in childhood obesity and to explore the potential mediating role of ferroptosis-related genes in the association between plasma metabolites and childhood obesity risk.
methodsA bidirectional two-step Mendelian randomization (MR) approach was applied, leveraging publicly available genome-wide association study (GWAS) datasets to analyze the causal relationship among 1400 plasma metabolites, 159 ferroptosis-related genes, and childhood obesity. In the first step, protein quantitative trait loci (pQTL) data corresponding to ferroptosis-related genes were identified as mediators to evaluate the causal effects of plasma metabolites and ferroptosis-related genes on childhood obesity. In the second step, MR analysis was conducted on ferroptosis-related genes and plasma metabolites identified in the first step to confirm their causal association. The inverse-variance weighted (IVW) method was primarily used for meta-analysis, while MR-PRESSO was employed to detect pleiotropy and outliers.
resultsFour ferroptosis-related genes (SMPD1 and SIRT3 suppressing obesity, GSTZ1 and ADAMTS13 promoting obesity) and nine plasma metabolites were found to be significantly associated with childhood obesity (six negatively correlated and three positively correlated). Further mediation analysis indicated that the ferroptosis mechanism regulated by SMPD1 and SIRT3 partially mediated the association between specific plasma metabolites and childhood obesity, with the highest mediation proportion reaching 9.62%. Sensitivity analysis confirmed the robustness of the results (no heterogeneity or horizontal pleiotropy), and reverse Mendelian randomization ruled out causal interference.
conclusionThis study is the first to reveal, through Mendelian randomization analysis, the potential mediating role of ferroptosis-related genes in the association between plasma metabolites and childhood obesity. It suggests that the ferroptosis mechanism may influence childhood obesity risk by regulating specific metabolites. These findings contribute to understanding the role of ferroptosis in the pathological mechanisms of childhood obesity and provide novel molecular targets and intervention strategies for obesity prevention and treatment in children.
Indexed as
Identifiers
41249848What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.